Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




One Analyzer Combines Four Technologies

By LabMedica International staff writers
Posted on 27 Jul 2010
Four concurrent detection technologies enable a broad range of chemistry, immunoassay, and plasma protein testing on one machine.

The four methodologies are photometry, nephelometry, electrolyte detection, and advanced chemiluminescence. More...
Clinical laboratories will benefit from an integrated chemistry and immunoassay system with the productivity and expanded capacity of high-volume automation.

The analyzer is the Dimension Vista 1500 System, which with its new connectivity to the ADVIA Automation track provides additional configuration options that help clinical laboratories customize workflow solutions to address unique operational needs. Adding to ADVIA automation options for customers is the new Centrifuge Module that together with the recently released decapper module offers one of the fastest centrifugation throughputs available to help decrease preanalytical processing time of patient samples. The centrifuge quickly and efficiently processes urgent and routine samples in intermixed tubes and caps with minimal attention or intervention by the operator.

Dimension Vista Systems are manufactured by Siemens Healthcare Diagnostics (Siemens; Deerfield, IL, USA). The Vista 1500 has a capacity for 600-800 samples onboard simultaneously, and it will process up to 2,000 tests per hour. The assay menu is very comprehensive, including general chemistry, electrolytes, diabetes testing, cancer marker monitoring, and cardiovascular assessment. Nephropathies, iron metabolism, and autoimmune testing are all encompassed in the analyzer.

David Hickey, executive vice president of the company, said, "Now, with the ability to connect the Dimension Vista 1500 System with ADVIA high-volume automation, laboratories can combine the best of both worlds—ultra integration with speed and efficiency.”

Related Links:

Siemens




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Nucleic Acid Purification Instrument
QIAsymphony Connect
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.